Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ea Series TrustALPHA ARCH 1 3 ALPHA ARCH 1-3 | 0 | 318,120 | +318,120 | $0 | $33.87M | 9.25% | +$33.87M |
| Roivant Sciences Ltd.SHS(ROIV) | 1,256,591 | 2,791,870 | +1,535,279 | $14.11M | $29.43M | 8.03% | +$15.31M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 9,500 | 180,145 | +170,645 | $1.82M | $26.92M | 7.35% | +$25.10M |
| Protagonist Therapeutics Inc | 200,859 | 785,655 | +584,796 | $4.61M | $22.73M | 6.21% | +$18.12M |
| Cytokinetics, Incorporated(CYTK) | 92,082 | 319,510 | +227,428 | $7.69M | $22.40M | 6.12% | +$14.71M |
| Keros Therapeutics, Inc.(KROS) | 688,316 | 338,243 | -350,073 | $27.37M | $22.39M | 6.11% | -$4.98M |
| Royalty Pharma plcCL A(RPRX) | 1,321,834 | 721,301 | -600,533 | $37.13M | $21.91M | 5.98% | -$15.22M |
| BridgeBio Pharma, Inc.(BBIO) | 185,137 | 549,804 | +364,667 | $7.47M | $17.00M | 4.64% | +$9.53M |
| Merrimack Pharmaceuticals In | 549,418 | 902,350 | +352,932 | $7.37M | $13.33M | 3.64% | +$5.96M |
| Ascendis Pharma A/SADR(ASND) | 45,884 | 48,584 | +2,700 | $5.78M | $7.34M | 2.01% | +$1.57M |
| Arbutus Biopharma Corporation(ABUS) | 3,468,824 | 2,074,183 | -1,394,641 | $8.67M | $5.35M | 1.46% | -$3.32M |
| Avrobio Inc | 50,147 | 3,954,857 | +3,904,710 | $68.2K | $5.06M | 1.38% | +$4.99M |
| BeOne Medicines AGADR(ONC) | 2,028 | 31,505 | +29,477 | $365.8K | $4.93M | 1.35% | +$4.56M |
| Alkermes plcSHS(ALKS) | 0 | 156,600 | +156,600 | $0 | $4.24M | 1.16% | +$4.24M |
| Helix Acquisition Corp IiCL A | 0 | 403,500 | +403,500 | $0 | $4.20M | 1.15% | +$4.20M |
| Sarepta Therapeutics, Inc.(SRPT) | 8,062 | 31,105 | +23,043 | $777.4K | $4.03M | 1.10% | +$3.25M |
| Endeavor Group Hldgs IncCL A | 2,500 | 155,250 | +152,750 | $59.3K | $3.99M | 1.09% | +$3.94M |
| Achieve Life Sciences Inc | 0 | 875,000 | +875,000 | $0 | $3.98M | 1.09% | +$3.98M |
| Fusion Pharmaceuticals Inc | 0 | 177,200 | +177,200 | $0 | $3.78M | 1.03% | +$3.78M |
| Absci Corporation | 0 | 586,984 | +586,984 | $0 | $3.33M | 0.91% | +$3.33M |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 180,911 | +180,911 | $0 | $3.30M | 0.90% | +$3.30M |
| Fulcrum Therapeutics, Inc.(FULC) | 637,405 | 339,825 | -297,580 | $4.30M | $3.21M | 0.88% | -$1.09M |
| Q32 Bio Inc.(QTTB) | 0 | 187,567 | +187,567 | $0 | $3.20M | 0.87% | +$3.20M |
| Applied Therapeutics Inc | 0 | 456,588 | +456,588 | $0 | $3.10M | 0.85% | +$3.10M |
| Spdr Ser TrBLOOMBERG 1 3 MO ST STR BLO 1 ETF | 32,000 | 32,500 | +500 | $2.92M | $2.98M | 0.81% | +$59.0K |
| Pfizer Inc.(PFE) | 17,400 | 106,342 | +88,942 | $500.9K | $2.95M | 0.81% | +$2.45M |
| Vanguard Bd Index FdsVANGUARD ULTRA VANGUARD ULTRA | 50,206 | 55,206 | +5,000 | $2.48M | $2.74M | 0.75% | +$253.3K |
| J P Morgan Exchange Traded FULTRA SHRT INC ULTRA SHRT ETF | 49,000 | 54,000 | +5,000 | $2.46M | $2.72M | 0.74% | +$263.0K |
| Ishares TrSHORT TREAS BD | 24,500 | 24,500 | 0 | $2.70M | $2.71M | 0.74% | +$10.0K |
| Solid Biosciences Inc | 1,000 | 203,204 | +202,204 | $6.1K | $2.71M | 0.74% | +$2.70M |
| WisdomTree, Inc.FLOATNG RAT TREA(WT) | 56,000 | 53,000 | -3,000 | $2.81M | $2.67M | 0.73% | -$148.1K |
| Cellectar Biosciences, Inc.(CLRB) | 1,378,082 | 642,541 | -735,541 | $3.82M | $2.56M | 0.70% | -$1.26M |
| OmniAb, Inc.(OABI) | 478,171 | 451,485 | -26,686 | $2.95M | $2.45M | 0.67% | -$503.3K |
| Centessa Pharmaceuticals PlcADS | 0 | 206,856 | +206,856 | $0 | $2.34M | 0.64% | +$2.34M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 2,300 | +2,300 | $0 | $2.21M | 0.60% | +$2.21M |
| iBio, Inc.CON NEW(IBIO) | 0 | 600,000 | +600,000 | $0 | $2.19M | 0.60% | +$2.19M |
| Corteva, Inc.(CTVA) | 58,000 | 37,400 | -20,600 | $2.78M | $2.16M | 0.59% | -$622.5K |
| Beyond Air, Inc.(XAIR) | 0 | 1,204,820 | +1,204,820 | $0 | $2.10M | 0.57% | +$2.10M |
| Immunovant, Inc.(IMVT) | 134,125 | 60,763 | -73,362 | $5.65M | $1.96M | 0.54% | -$3.69M |
| Ligand Pharmaceuticals Incorporated(LGND) | 0 | 26,800 | +26,800 | $0 | $1.96M | 0.53% | +$1.96M |
| Ssga Active Etf TrULT SHT TRM BD ST STR UL BD ETF | 61,264 | 47,684 | -13,580 | $2.47M | $1.93M | 0.53% | -$542.6K |
| Spyre Therapeutics, Inc.(SYRE) | 6,440 | 49,500 | +43,060 | $138.6K | $1.88M | 0.51% | +$1.74M |
| Schrödinger, Inc.(SDGR) | 2,000 | 63,586 | +61,586 | $71.6K | $1.72M | 0.47% | +$1.65M |
| Spero Therapeutics, Inc.(SPRO) | 1,067,711 | 926,929 | -140,782 | $1.57M | $1.59M | 0.44% | +$24.8K |
| uniQure N.V.SHS(QURE) | 0 | 292,850 | +292,850 | $0 | $1.52M | 0.42% | +$1.52M |
| Apellis Pharmaceuticals Inc COM | 0 | 25,700 | +25,700 | $0 | $1.51M | 0.41% | +$1.51M |
| Eli Lilly and Company(LLY) | 0 | 1,865 | +1,865 | $0 | $1.45M | 0.40% | +$1.45M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 111,326 | 101,626 | -9,700 | $1.16M | $1.43M | 0.39% | +$271.7K |
| Ngm Biopharmaceuticals Inc | 0 | 816,581 | +816,581 | $0 | $1.30M | 0.35% | +$1.30M |
| Viking Therapeutics, Inc.(VKTX) | 254,151 | 14,401 | -239,750 | $4.73M | $1.18M | 0.32% | -$3.55M |
| Kiniksa Pharmaceuticals LtdCL A | 105,000 | 59,700 | -45,300 | $1.84M | $1.18M | 0.32% | -$663.8K |
| enVVeno Medical Corporation(NVNO) | 0 | 201,728 | +201,728 | $0 | $1.10M | 0.30% | +$1.10M |
| Arvinas, Inc.(ARVN) | 0 | 26,200 | +26,200 | $0 | $1.08M | 0.30% | +$1.08M |
| Delcath Systems, Inc.(DCTH) | 231,302 | 218,973 | -12,329 | $962.2K | $1.04M | 0.29% | +$82.3K |
| Cerevel Therapeutics Hldng I | 110,700 | 24,259 | -86,441 | $4.69M | $1.03M | 0.28% | -$3.67M |
| AngioDynamics, Inc.(ANGO) | 132,962 | 153,362 | +20,400 | $1.04M | $900.2K | 0.25% | -$142.2K |
| Silence Therapeutics plcADS(SLN) | 190 | 40,090 | +39,900 | $3.3K | $865.9K | 0.24% | +$862.6K |
| Gossamer Bio, Inc.(GOSS) | 713,028 | 732,628 | +19,600 | $650.6K | $864.5K | 0.24% | +$213.9K |
| Global Star Acquisition IncCL A | 80,000 | 80,000 | 0 | $848.0K | $856.8K | 0.23% | +$8.8K |
| Voyager Therapeutics, Inc.(VYGR) | 185,894 | 91,534 | -94,360 | $1.57M | $852.2K | 0.23% | -$716.8K |
| Perspective Therapeutics, Inc.(CATX) | 42,200 | 676,725 | +634,525 | $17.0K | $805.3K | 0.22% | +$788.3K |
| Keen Vision Acquisition CorporationUNIT 99 99 9999(KVACF) | 75,000 | 75,000 | 0 | $777.0K | $788.3K | 0.22% | +$11.3K |
| Actinium Pharmaceuticals, Inc.(ATNM) | 0 | 100,000 | +100,000 | $0 | $783.0K | 0.21% | +$783.0K |
| Kiora Pharmaceuticals Inc | 0 | 1,100,000 | +1,100,000 | $0 | $776.6K | 0.21% | +$776.6K |
| Acasti Pharma IncCL A | 34,532 | 217,381 | +182,849 | $99.8K | $744.5K | 0.20% | +$644.7K |
| Morphic Hldg Inc | 0 | 19,701 | +19,701 | $0 | $693.5K | 0.19% | +$693.5K |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 16,000 | +16,000 | $0 | $643.2K | 0.18% | +$643.2K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 16,000 | +16,000 | $0 | $627.8K | 0.17% | +$627.8K |
| TherapeuticsMD, Inc.(TXMD) | 272,160 | 272,160 | 0 | $612.4K | $623.2K | 0.17% | +$10.9K |
| West Pharmaceutical Services, Inc.(WST) | 0 | 1,500 | +1,500 | $0 | $593.6K | 0.16% | +$593.6K |
| Indivior Plc | 24,101 | 27,601 | +3,500 | $368.0K | $591.2K | 0.16% | +$223.2K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 0 | 12,400 | +12,400 | $0 | $537.3K | 0.15% | +$537.3K |
| Tmt Acquisition CorpSHS | 50,000 | 50,000 | 0 | $530.0K | $534.5K | 0.15% | +$4.5K |
| Janux Therapeutics, Inc.(JANX) | 0 | 14,000 | +14,000 | $0 | $527.1K | 0.14% | +$527.1K |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 35,608 | +35,608 | $0 | $523.4K | 0.14% | +$523.4K |
| Ab Active Etfs IncULTRA SHORT INCM ULTRA SHORT INCM | 10,000 | 10,000 | 0 | $502.9K | $505.2K | 0.14% | +$2.3K |
| Stevanato Group S P A ORD SHS | 0 | 15,500 | +15,500 | $0 | $497.6K | 0.14% | +$497.6K |
| Pgim Etf TrPGIM ULTRA SH BD PGIM ULTRA SH BD | 10,000 | 10,000 | 0 | $493.9K | $497.0K | 0.14% | +$3.1K |
| Vistagen Therapeutics, Inc.(VTGN) | 245,502 | 89,938 | -155,564 | $1.26M | $474.9K | 0.13% | -$787.0K |
| Aerovate Therapeutics Inc | 0 | 15,900 | +15,900 | $0 | $470.2K | 0.13% | +$470.2K |
| Tyra Biosciences, Inc.(TYRA) | 0 | 28,300 | +28,300 | $0 | $464.1K | 0.13% | +$464.1K |
| Arya Sciences Acqu Corp IvCL A | 0 | 40,930 | +40,930 | $0 | $459.6K | 0.13% | +$459.6K |
| Equillium, Inc.(EQ) | 6,500 | 198,775 | +192,275 | $4.7K | $459.2K | 0.13% | +$454.5K |
| Intelligent Bio Solutions In | 0 | 108,250 | +108,250 | $0 | $456.8K | 0.12% | +$456.8K |
| Apogee Therapeutics Inc | 0 | 6,000 | +6,000 | $0 | $398.7K | 0.11% | +$398.7K |
| Milestone Pharmaceuticals Inc.(MIST) | 0 | 202,460 | +202,460 | $0 | $362.4K | 0.10% | +$362.4K |
| Bicycle Therapeutics PlcADS | 74,825 | 14,430 | -60,395 | $1.35M | $359.3K | 0.10% | -$993.5K |
| Zai Lab LimitedADR(ZLAB) | 20,000 | 22,000 | +2,000 | $546.6K | $352.4K | 0.10% | -$194.2K |
| Guardant Health, Inc.(GH) | 0 | 17,000 | +17,000 | $0 | $350.7K | 0.10% | +$350.7K |
| Yarrow Bioscience Inc(YARW) | 0 | 110,091 | +110,091 | $0 | $338.0K | 0.09% | +$338.0K |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 155,000 | +155,000 | $0 | $337.9K | 0.09% | +$337.9K |
| Oak Woods Acquisition CorpCL A | 30,000 | 30,000 | 0 | $315.9K | $322.5K | 0.09% | +$6.6K |
| Screaming Eagle Acquisitn CoCL A | 30,000 | 30,000 | 0 | $318.0K | $321.0K | 0.09% | +$3.0K |
| Alector Inc | 0 | 52,500 | +52,500 | $0 | $316.1K | 0.09% | +$316.1K |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 24,000 | +24,000 | $0 | $309.8K | 0.08% | +$309.8K |
| Jvspac Acquisition CorpUNIT 03 11 2024 | 0 | 30,000 | +30,000 | $0 | $309.0K | 0.08% | +$309.0K |
| Alphabet Inc.CL A(GOOG) | 0 | 2,000 | +2,000 | $0 | $301.9K | 0.08% | +$301.9K |
| Spruce Biosciences Inc | 0 | 365,216 | +365,216 | $0 | $287.0K | 0.08% | +$287.0K |
| Context Therapeutics Inc.(CNTX) | 0 | 205,934 | +205,934 | $0 | $284.2K | 0.08% | +$284.2K |
| SanofiADR(SNY) | 0 | 5,500 | +5,500 | $0 | $267.3K | 0.07% | +$267.3K |